It is worth noting that during Covid-19 pandemic, several parts of the world (including China, US, Mexico, India and some European countries) started leveraging robots to spray disinfectants, hand sanitizer-dispensing robots, patrol robots (robots for checking temperature of visitors in hospitals), robot as chefs, robots in food service and preparation, robots for delivering groceries and ninja robots (which can deliver essential items to those infected).
The global medical robotics market size is estimated to grow from $ 10.1 billion in 2024 to $ 31.3 billion by 2035, at a CAGR of 10.8% during the forecast period, till 2035.
This has demonstrated some significant improvements in healthcare system and contributed to the prevention of the spread of coronavirus infection. Moreover, the use of robots in healthcare is rapidly gaining traction due to their ability to overcome transportation barriers. Hence, with the expanding use cases and continuous advancements in medical robotics, the adoption of medical robots in healthcare is poised to transform the way medical care is delivered, bringing about significant benefits for patients, healthcare providers, and society as a whole.
Surgical Robots Market: Market Landscape
During our research, we were able to identify over 110 surgical robot companies are engaged in the development of surgical robots intended to provide support to surgeons. As can be observed in the figure, most of the players (37%) in this domain were established between 2016-2020, and over 70% of them were established post 2010. This rise in the number of surgical robotics developers could be attributed to the growing demand for automation in the surgical procedures, along with the advent of better computational, engineering and other technological capabilities required in order to develop such products.
Moreover, the surgical robots market is currently dominated by over 50% small and very small players, followed by 31% mid-sized surgical robot companies. This suggests that the surgical robotics industry is enticing for new entrants and startups. Further, this growth can also be attributed to the evolving need for automation in conducting complex medical procedures in the healthcare industry, along with the promising future prospects for remote surgery.
Most of the surgical robot companies are currently focused on the development of one surgical robot. These companies are continuously innovating and making strides towards developing surgical robots for enhanced surgical outcomes. However, only a small proportion (~20%) of the companies are engaged in the development of more than one surgical robot. Further, close to 40% of the companies offer surgical robots to treat patients undergoing orthopedic surgery; of these, 27% companies offer surgical robots to diagnostic laboratories.
Foreseeing lucrative returns, many public and private investors have made investments worth usd 4.7 billion since 2019; the funding activity is well distributed across different geographical regions.
During our research, we came across several instances of funding and investments that have been made into surgical robot companies, during the forecast period. It is worth noting that maximum number of funding instances (23%) were reported in 2023. Moreover, in 2023, four companies raised funding via more than one funding round, these include (in alphabetical order) Asensus Surgical, Galen Robotics, Ganymed Robotics and Microbot Medical.
The overall trend of investments being made in this domain has been very promising, with over USD 3.6 billion invested in this domain over the last few years. Furthermore, the US, Canada, France, China and Israel (in no particular order) have emerged to be the key hubs for surgical robotics startups. Notably, the maximum number of funding instances (48%) were reported by companies based in North America.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/medical-robotics-market.html
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.
Contact:
Roots Analysis
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Website: https://www.rootsanalysis.com/
